Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.590
+0.140 (9.66%)
Jan 9, 2026, 9:53 AM EST - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $99 million as of January 9, 2026. Its market cap has increased by 8.11% in one year.
Market Cap
99.00M
Enterprise Value
33.10M
1-Year Change
8.11%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $99.00M, a decrease of -81.10%. That is a compound annual growth rate of -32.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 88.42M | 23.48% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |